CRISPR-Cas9-based genome editing has transformed the life sciences, enabling virtually unlimited genetic manipulation of genomes: The RNA-guided Cas9 endonuclease cuts DNA at a specific target sequence and the resulting double-strand breaks are mended by one of the intrinsic cellular repair pathways. Imprecise double-strand repair will introduce random mutations such as indels or point mutations, whereas precise editing will restore or specifically edit the locus as mandated by an endogenous or exogenously provided template. Recent studies indicate that CRISPR-induced DNA cuts may also result in the exchange of genetic information between homologous chromosome arms. However, conclusive data of such recombination events in higher eukaryotes are lacking. Here, we show that in Drosophila, the detected Cas9-mediated editing events frequently resulted in germline-transmitted exchange of chromosome arms-often without indels. These findings demonstrate the feasibility of using the system for generating recombinants and also highlight an unforeseen risk of using CRISPR-Cas9 for therapeutic intervention.
Introduction
CRISPR-Cas9-based genome editing has revolutionized genetic research, triggering the development of a plethora of technologies and applications that provide unprecedented control over genes in a growing list of model species (1, 2, 3, 4, 5, 6, 7, 8) . CRISPR systems allow us to edit, engineer, or regulate genomes, hold great promise for clinical applications, and are likely to be used to treat diseases with genetic underpinnings, including cancer (9, 10) . Genome editing is achieved by precisely targeting the nuclease activity of a modified bacterial protein (Cas9) via a user-defined guide RNA to a specific DNA sequence (1) . The resulting DNA double-strand breaks (DSBs) are repaired either by the error-prone nonhomologous end joining (NHEJ) or homology-directed repair (11) . For refined and precise genome editing purposes, homology-directed repair is harnessed to copy a specific DNA template (single-stranded or double-stranded) into the target site (2, 9, 12, 13) . In contrast, NHEJ ligates the two broken ends of the DNA without a donor template, often resulting in random insertions or deletions (indels) that can disrupt coding sequences at the target site (for review see reference 14) . However, with directly ligateable ends, NHEJ may lead to accurate repair of close and concurrent DSBs (15, 16, 17, 18) , also when induced by Cas9 (19, 20, 21, 22) . The ability of CRISPR-Cas9 to introduce several concurrent DSBs at defined positions has enabled engineering of tumor-associated chromosomal translocations resembling those observed in cancers, and hence to establish and test novel in vitro and in vivo tumor models (2, 23, 24, 25) . Sadhu et al. (26) leveraged the CRISPR-Cas9 system to produce other chromosomal rearrangements, generating targeted mitotic recombination events in yeast to enable the fine mapping of trait variants. The authors deliberately induced a single DSB in one of the homologous chromosomes in a diploid yeast strain and achieved homologous recombination-based "loss of heterozygosity" events within 20 kb of the target site. Additional reports suggest that recombination in mitotic cells is not restricted to yeast but may also occur in other species such as houseflies (27) and tomatoes (28) . What is currently missing is a solid confirmation of such events and data on their frequency in different species.
Here, we set out to examine the occurrence and frequency of genetic exchanges between homologous chromosome arms initiated by Cas9-induced DSBs. We show that Cas9-triggered DSBs induce germline-transmitted recombination between homologous chromosome arms in up to 39% of the CRISPR events in Drosophila. Although these findings expand the tool-box of CRISPR-based genome manipulation in research, they also raise concerns about the use of gene editing in therapeutic settings. a system for activating transgene expression through NHEJ-based repair. The system, which we named CIGAR (CRISPR-Induced Gene Activator), allows activation of transgene expression after CRISPRinduced DSBs. The principle of the CIGAR system is based on activation of gene expression if, and only if, a unique CRISPR-Cas9 target sequence has been cleaved and rearranged by NHEJ (Fig 1) . CIGAR consists of four elements: (i) the ubiquitin-p63E promoter to drive gene expression in every cell (31) , (ii) a so-called "shifter" sequence, (iii) a flexible linker sequence inserted 39 of the shifter sequence (32) , and (iv) a reporter cDNA (lacking a translational start codon) followed by the 39UTR of the Drosophila tubulin α1 gene. The functional core of the CIGAR reporter lies within the shifter sequence, which contains optimized translational START codons covering all three frames upstream of a unique 20-nt CRISPR target sequence (33, 34 Table S1 ). The site of the DSB was in part marked by indels.
From these results, we concluded that in these animals, recombination events had occurred at the site of the Cas9-induced DSBs. We would like to emphasize that the term recombination is used here to describe the exchange of genetic material between homologous chromosome arms initiated by CRISPR-induced DSBs. Because Cas9 activity may often cause the break of both homologs, such recombination events may not only be based on homologous recombination but may also result by breakage/fusion events involving NHEJ that lead to a crosswise ligation of the chromosome arms (15, 16, 17, 18, 19, 20, 21, 22) . From our results, however, we cannot infer which repair mechanism was involved in the exchange of genetic information between homologous chromosome arms.
In the experiment described above, the CIGAR transgenes were located at position 5D on the X-chromosome that shows native recombination activity in the female germline (35) . To further test if CRISPR-Cas9 could induce efficient site-specific recombination, we turned to the fourth chromosome for which normally no naturally occurring recombination is observed (36, 37, 38) . We first generated transgenic animals harboring the CIGAR eGFP and CIGAR mCherry construct at position 102F on the two homologous arms of chromosome 4, in addition to nos-Cas9 and U6:3-sgRNA CIGAR (1, 2) . Such individuals were crossed to yw animals, and their offspring were scored for recombination events (Fig 2C, see the Materials and Methods section for details). Animals were randomly picked from 13 crosses immediately after hatching and analyzed for the sequences flanking the target site (Tables S2 and S3 ). This revealed that in 41 of 156 animals, recombination events had occurred (Fig 2B; for details see the Materials and Methods section). Thus, as described above for the X chromosome, numerous CRISPR-mediated recombination events were observed on the fourth chromosome (39% of the detected Cas9-triggered events, i.e., 41 of 105 CRISPR events).
CRISPR-induced recombination between two distant phenotypic markers
In the above experiments, recombination was induced between homologous chromosome arms for which the nt at the Cas9 target site as well as the flanking sequences (coding for the fluorescent proteins) differed. However, the recombination events could only be demonstrated by sequence analysis of the immediate vicinity of the CRISPR site; more distant phenotypic markers were not present on these chromosomes. Therefore, we could not rule out that, at least in some cases, other mechanisms, such as gene conversion, were responsible for the observed sequence exchange between the two CIGAR reporters in trans (39) .
To confirm that indeed a complete exchange of the homologous chromosome arms occurs distal to the CRISPR-Cas9-induced DSBs, we used two visible markers separated by more than 100 kb ( offspring, we recovered 253 putative recombinants ( Fig 3D) . Of these 253 animals, we further characterized 57 deriving mostly from independent crosses. 21 of the 57 animals turned out to be true germline-transmitted recombinants that were homozygous viable (TR-A and TR-B in Fig 3E and Tables S4 and S5 ). Molecular analysis of the Cas9 target site revealed that 19 of these 21 recombinants did not contain an indel lesion at the CRISPR site (sequence traces with indels are shown in Table S4 ). Extrapolating from the 21 confirmed recombinants (out of 57) to the 253 putative recombinants (out of 8,604 F1 animals), the frequency of CRISPR-mediated targeted recombination in this experiment is estimated to be~1.1%. This frequency is at least four orders of magnitude higher than that of the rare spontaneous recombination rate predicted for chromosome 4 (37).
CRISPR-induced DSBs may lead to loss of chromosomal structures
The remaining 36 (out of 57) putative recombinants recovered from the above experiment were homozygous lethal and exhibited position effect variegation (PEV; Fig 4A and B) in the adult compound eye. PEV in the eye occurs if the mini-white gene (w + ), used as transgene reporter, is juxtaposed to heterochromatic regions via chromosomal rearrangements or translocations (42, 43, 44, 45) . In particular, the proximity of the mini-white gene to the heterochromatic telomere regions may lead to PEV (46) . We, therefore, reasoned that in animals showing PEV, the Cas9-based editing led to a loss of chromosome structures distal to the DSB and consequently, expression of the miniwhite gene of the CIGAR transgene is variably silenced. Similar events have been reported for X-ray-induced DSBs on the fourth chromosome (47 animals. Without exception, the tested PEV chromosomes were unable to complement the sv Δ122 mutation, indicating that they must have lost distal parts of chromosome 4.
Recombination is triggered by, and confined to the site of, Cas9-induced DSBs
Finally, to exclude that Cas9-induced DSBs merely stimulate nonspecific recombination (NSR) on the fourth chromosome (i.e., markers. G0 animals were crossed with yw animals to score recombination events between the y + and the w + marker (Fig 4D) . We screened more than 13,000 F1 animals but did not observe a single recombination event between the markers (NSR-A or NSR-B in Fig 4E, see the Materials and Methods section for details). These results are consistent with the notion that no spontaneous recombination occurs between the fourth chromosomes and that the recombination observed in the previous experiments above (Fig 3, TR) were triggered by, and confined to the site of, CRISPR-induced DSBs. In summary, our experiments involving chromosome 4 revealed that germ-line-transmitted recombinants can be recovered at frequencies ranging from about 1.1% (recombination between visible markers) to 26% (recombination between CIGAR constructs; see the Materials and Methods section). These percentages represent the number of recombinants recovered from the total number of animals analyzed. When only the detected Cas9-mediated events are taken into consideration, the frequency of recombination was even 39%.
Discussion
Our results show that a substantial amount of CRISPR-Cas9-induced DSBs result in exchanges between homologous chromosome arms. Importantly, the recombination events we see occur in multiple experimental settings and not only under specific conditions. In this context, it is important to point out that recombination events observed in experiments where Cas9 has been provided as recombinant protein exclusively occurred in mitotic and not in meiotic cells: a study by Burger and colleagues shows that fluorescently labeled Cas9 RNP complexes are detectable until about 18 h after injection (40) . In Drosophila, however, the first meiotic divisions occur at much later timepoints (i.e., in males in the Fig 3D) , 57 were characterized in more detail. 21 were true recombinants, whereas 36 animals had a loss of chromosomal structures distal to the CRISPR target site which manifested in PEV, that is, variable expression of the mini-white gene. (B) Fly exhibiting PEV is shown. The genotype of the fly and the loss of chromosomal structures distal to the cut site are shown below the image. Important to note is that only the loss of distal chromosome structures of the w + chromosome can be scored from the TR screen (described in Fig 3) . The corresponding loss of sv spa-pol on the Dp(1;4)1021,y + chromosome is phenotypically identical to UR-B (Fig 3E) and will not be recovered from the screen. third instar larvae, about 3-4 d after injection and in females at early pupal stages (48)), likely excluding residual activity of Cas9 RNPs.
In experiments where Cas9 protein and the sgRNAs are provided via transgenes (49, 50) , Cas9 expression is driven by the nanos (nos) promoter and the Cas9 transgene contains the nos 39UTR recapitulating germline-specific nos expression, transcript localization, and translational control (49, 51, 52) . Hence, Cas9 is maternally provided to the offspring and likely not expressed zygotically during embryogenesis (53) . In females, Nos is available during mitotic divisions in the germline stem cells as well as in those that later on form the 16-cell cyst in the germline. It should not be present in the growing oocyte where meiosis would occur (53) . In the male germline, nos expression seems to be essential during spermatogenesis (54) . Loss of nos expression leads to various phenotypes with strongest effects on the number of primary spermatocytes that are created through mitotic divisions. Together, these arguments suggest that also in case the CRISPR reagents are provided via transgenes, recombination events occurred preferentially in mitotic cells. However, because the nos-Cas9 transgene is not inserted into the nos locus, presence of Cas9 protein and extension recombination events in meiotic cells cannot strictly be ruled out.
One reason why CRISPR-induced recombination has largely remained unnoticed in genetic model organisms is that DSBs are frequently repaired without resulting indels and thus cannot be detected by next-generation sequencing, preventing any follow-up validation of broader effects. When detected using genetic and sequencing validation, we noted variable recombination rates in our experiments. We attribute this variability to three experimental aspects. First, the different Cas9 target sites may have different cutting and recombination efficacy (30, 55) . Second, individual crosses may yield different numbers of progeny harboring CRISPRderived indels (i.e., CRISPRed (G0) animals transmit a variable number of mutant alleles to the next generation, ranging from 0 to 100% as shown for the recovery of a nonfunctional y allele, see Fig 2  in reference 49) . Third, in our experiments, different methods were used to introduce Cas9 and gRNAs, a circumstance that likely contributed to the different frequencies of recombinants recovered (49) .
The Cas9-mediated site-specific chromosomal recombination described here opens up a number of new avenues and considerations for genome engineering. We demonstrate that in Drosophila, Cas9-mediated DSBs can be used to generate recombination at a predefined site between chromosomal locations that are in close vicinity. Unlike for site-specific recombination based on Flp (56, 57) , no recombinase target sites need to be present. Thus, CRISPR-mediated site-specific recombination enables the combination of two known mutations situated in different alleles of one and the same gene into a single (double-)mutant allele. Moreover, it could be used to study permutations of mutant alleles in tightly linked genes such as members of a Hox gene cluster (58) . Especially in vertebrates, such as mouse or zebrafish, CRISPR-induced recombination holds promise for a number of applications, including generation of complex mutant alleles in the same locus (59) . Also, in Drosophila, Cas9-mediated recombination enables experiments that were previously impossible because of low or absent recombination rates. For example, by providing sgRNAs or Cas9 activity in a tissue-specific manner, it may become possible to generate specific mutant clones for genes located on the fourth chromosome. Finally, targeted Cas9-mediated recombination could potentially be used in epigenetic studies to determine the effects of swapping promoters, including their epigenetic marks, between maternal and paternal genes.
On the other hand, our findings that recombination between homologous chromosome arms may be triggered upon Cas9-induced DSBs underscore the need for caution in applying CRISPR-based genetic interventions in animals or humans (60): Unrecognized CRISPR-induced recombination events (i.e., no visible indels at the target site) may lead to loss-of-heterozygosity events, generating cells with unnoticed homozygosity for imprinted genes or recessive mutations located distal to the Cas9 target site, which may have unforeseen consequences.
Moreover, we observed that CRISPR-based engineering can lead to loss of chromosome material distal to the locus of the DSB (Fig 4B) . We could observe such events in our system because haplo-four animals (harboring only a single copy of the fourth chromosome) are viable (61) . Under most circumstances, and likely in most organisms, such events would lead to the death of the affected cells because of haploinsufficiency. In this context, recent work suggested that Cas9 induces mutations in human cells and mice that are larger than anticipated (62) . Therefore, it is imperative to routinely consider broader chromosomal alternations as possible outcome when applying CRISPR technologies in translational medicine.
Materials and Methods

Plasmid construction
Unless otherwise noted, the plasmids were constructed by standard molecular cloning methods. When plasmids contain newly synthesized nt sequences via PCR, oligonucleotide synthesis, or mutagenesis, the sequences were verified by DNA sequencing. pUbiattB The StuI-ubiquitin p63E promoter (ubi)-EcoRI fragment from pCaSpR3-Up2-RX polyA was subcloned into a pBluescript (pBS) vector between the EcoRI and XhoI sites using blunt-end ligation. The EcoRI-ubi-Acc65I fragment from the resulting plasmid was subcloned into pEPattB (63) using the EcoRI and Acc65I sites.
pUbiattB-CIGAR eGFP
To create the pUbiattB-CIGAR eGFP reporter, the shifter sequence (containing optimized translational START codons covering all three frames upstream of a unique 20-nt CRISPR target sequence), a unique gRNA target sequence (referred to as sgRNA-1), the linker sequence, and the eGFP gene were designed (as shown below), synthesized by GenScript, and delivered ligated into the pUC57-Kan vector (pCIGAR-D0).
The pCIGAR-D0 insert:
The synthetic sequence was excised with KpnI and EcoRI and ligated into pre-double-digested pKB342 vector in line with a tubulin 39 trailer, transformed, and purified, resulting in pKB342_CI-GAR. To remove the CIGAR sequence including the tubulin trailer, pKB342_CIGAR was then digested with KpnI and XbaI, and the fragment was ligated into a KpnI-and XbaI-digested pUbiattB vector containing an ubiquitin-p63E promoter (see above). This resulted in the final product referred to as pUbiattB-CIGAR eGFP .
pUbiattB-CIGAR mCherry
The same sequential digestions and ligation as for the making of the pUbiattB-CIGAR eGFP were used for the construction of the pUbiattB-CIGAR mCherry . The only difference was in the design of the target site; the gRNA (sgRNA-2) has a different unique target sequence and contains the mCherry gene as the fluorescent marker. The insert ligated into the pUC57-Kan vector was ordered from GenScript.
The CIGAR mCherry insert:
The pCFD5 vector was a gift from Fillip Port (#73914; Addgene) (50) . pCFD5 is the main backbone containing the tRNA assembly prepared to insert multiple gRNAs. For our purposes, sgRNA-1 and sgRNA-2 were inserted via Gibson cloning into the pCFD5 vector (named pCFD5-F1) following the protocol described in the supplementary methods of pCFD5 cloning protocol. pCFD5 internal tRNA multi-gRNA Scaffold:
Through the process of Gibson cloning, both our sgRNA-1 and sgRNA-2 were inserted into the pCFD5 vector using primer (59-GCGGCCCGGGTTCGATTCCCGGCCGATGCACGGCGACAGCAGAACGTA-GCGTTTTAGAGCTAGAAATAGCAAG-39) for sgRNA-1 and (59-ATTT-TAACTTGCTATTTCTAGCTCTAAAACGTCAGGTGCTTGTCTCGGGGTGCAC-CAGCCGGGAATCGAACCC-39) for sgRNA-2.
IVT of sgRNA-3
IVT of sgRNAs were performed as described in reference 40. For IVT, we used MEGAscript (AM1334), and for the purification of the IVT products, we used Purification: MEGAclear (AM1908).
IVT oligo used specific for sgRNA-3: 59-GAAATTAATACGACTCACTATAGGCTGTTGATAAGCACGCAATCGTTT-TAGAGCTAGAAATAGC-39.
IVT oligo used sgRNA-R used for template PCR: 59-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCC-TTATTTTAACTTGCTATTTCTAGCTCTAAAAC-39.
Complementary sequences of the specific sgRNA primer and the sgRNA-R are shown in bold letters.
Cas9/sgRNA RNP injections
The concentration of SpCas9 injected was about 800 ng/μl SpCas9 (final concentration) and about 300 ng/μl of sgRNA (IVT; final concentration after purification). This corresponds roughly to a 1:2 ratio (SpCas9: sgRNA-3). SpCas9 has about 5× the molecular weight of the sgRNA.
The injection mix is prepared as follows (total volume of 10 μl): add sgRNA, ddH 2 O, and 10× incubation buffer NEB and mix thoroughly. Gently add the SpCas9 and mix again thoroughly by pipetting up and down. It is mandatory to add SpCas9 as the last ingredient because low salt concentrations may cause SpCas9 to precipitate (40) .
X μl sgRNA (IVT; to a final concentration of 320 ng/μl; corresponds to 1:2 ratio SpCas9: sgRNA).
1 μl 10× NEB incubation buffer. Y μl ddH 2 O (RNase free) to a total of 10 μl (X + Y = 6.5 μl). 2.5 μl SpCas9 (EnGen Cas9 NLS, NEB #M0646T; 3.22 μg; final concentration 0.8 μg/μl).
Mix gently and incubate the mix at 37°C for 2 min. Load the mix onto a column (Ultrafree-MC-HV 0.45
Spin for 1 min in a table-top centrifuge @14,000g. Reincubate the flow-through at 37°C for 2 min. Let the mix equilibrate at RT for~30 min before injection. Never put the mix back on ice.
Fly genetics
Crosses were done at 25°C. Unless noted otherwise, fly lines were obtained from the Bloomington Drosophila Stock Center (see the Acknowledgments section).
Transgenic CIGAR fly lines (integration into ZH-attP 5D [X chromosome] or ZH-attP 102F [fourth chromosome]) were generated by phiC31 integrase-mediated transgenesis (51, 64) . Individual strains were confirmed to carry the correct shifter sequence by sequencing the PCR product of the shifter sequence using primers CIGAR-fwd: CAACAAAGTTGGCGTCGATA and CIGAR The pCFD5-F1 containing U6:3-sgRNA CIGAR (1, 2) was inserted into the attP 40 site (#25709; Bloomington).
Fly images
The images were taken on Axio Zoom V16 (Zeiss) and were processed in Adobe Photoshop or Adobe Illustrator.
CRISPR-Cas9-induced recombination on the fourth chromosome (more detailed description).
To determine if we could also induce CRISPR/Cas9-mediated recombination on the fourth chromosome, we first generated flies harboring either a CIGAR eGFP or CIGAR mCherry construct on the fourth chromosome at position 102F (51). These animals are referred to as CIGAR eGFP,102F, w+ and CIGAR mCherry,102F, w+ , respectively. Activation of the reporters was achieved with the previously used tRNA spaced sgRNA-1,2 tandem array (U6:3-sgRNA CIGAR (1, 2) G0 females to yw males). The offspring of such crosses were first scored at the larval stage to identify animals with either an activated CIGAR eGFP,102F or CIGAR mCherry,102F reporter. This preselection was made to ascertain that DSBs occurred in both constructs enhancing the likelihood of detecting recombination events on the fourth chromosome in case they occur. 17 vials (crosses from 12 G0 males and 5 G0 females) containing GFP and mCherry-positive larvae were selected for further analysis. A total of 172 y,w + F1
animals harboring either a CIGAR eGFP,102F or CIGAR mCherry,102F reporter but lacking the sgRNA plasmid U6:pCFD5 (to avoid mosaic flies) from 13 of these crosses were randomly picked right after hatching. Single fly PCR of the target as well as part of the fluorophore region for the CIGAR reporters was performed for these 172 animals (Tables S2 and S3 ). PCR products and readable sequences were obtained in 156 cases. For the recombination experiments using the CIGAR transgenes on chromosome 4, we estimate the recombination frequency to be 26%: 41 recombinants identified/156 flies analyzed × 100 (see Fig 2C  for numbers) .
CRISPR-induced recombination between two phenotypic markers (TR in Fig 3) To confirm that indeed recombination between sister chromatids occurs after CRISPR-Cas9-induced DSBs, we tested if we could induce recombination between two visible markers that are separated by about 100 kb (Figs 3A and S3) putative recombinants were homozygous lethal (for more information on these 36 lines see "Cas9-induced DSBs may lead to loss of chromosomal structures" below).
We then investigated these animals by PCR specific for the CRISPR target site. Sequence analysis revealed that with the exception of two animals all CRISPR sites were without any indel (i.e., had a wild-type sequence; Tables S4 and S5 ). Interestingly, two recombinants from the same cross (G0 male) showed the same CRISPR mark (6-bp deletion). However, they had the complementary phenotype: Whereas one fly showed the y, w + , sv spa-pol phenotype, the other was phenotypically w, y + , sv + , indicating that we may have recovered both chromosomes from the same recombination event. A third recombined animal from the same cross showed no CRISPR mark and thus can be counted as independent recombination event.
Recombination experiment between two phenotypic markers (NSR in Fig 4) To assess if CRISPR-Cas9-induced DSBs in general would enhance the frequency of recombination away from the Cas9 target site, we repeated the experiment and assessed the recombination frequency between a y + marker on the short, left arm of chromosome 4
and the w + -marked CIGAR mCherry,102F inserted at 102F (see NSR in Fig   4C) . To use the same experimental conditions and to exclude that the addition of active Cas9 would also induce recombination elsewhere on the fourth chromosome, embryos of the genotype (yw; CIGAR mCherry,102F,w+ /Dp(1;4)1021,y + , sv spa-pol ) were injected with Cas9 protein complexed with in vitro-translated sgRNA-3. This again would induce DSBs 39 of toy located distal of CIGAR mCherry,102F
but should not have any influence on the recombination between the y + and the w + markers. G0 animals were this time crossed with yw animals to be able to score crossover events between the y + and the w + marker (Fig 4D) . As expected, F1 animals were phenotypically either yw + or y + w because the two markers normally segregate.
However, 11 phenotypically y + ,w + flies were recovered from a total of 13,220 analyzed offspring. To assess if the y + ,w + recovered animals were indeed spontaneous recombinants, or represented nondisjunction events (i.e., triplo-4 animals which are viable), we backcrossed such animals again against yw flies. Spontaneous recombination between y + and w + could be excluded as the abovementioned backcross would have only revealed phenotypically y + w + or yw flies. Instead, nondisjunction could be confirmed in all 11
cases because the backcross revealed phenotypically y + w + , yw, y + w, and yw + flies. We determined the non-disjunction rate for the fourth chromosome to be 1 in 1,200, which is similar to the one observed for the X chromosome (66) .
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